Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad
In This Article:
Hims stock surged into a profit-taking zone Friday after facing backlash over its provocative Super Bowl ad that criticized the makers of approved weight-loss drugs. On Friday, Sen. Richard Durbin (D-Ill.) and Sen. Roger Marshall (R-Kan.) sent a letter to acting Food and Drug Administration Commissioner Sarah Brenner asking the agency to investigate Hims for "misleading patients."
Terms and Privacy Policy